HealthCor Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.78M | Sell |
70,000
-789,240
| -92% | -$20.1M | 1.63% | 9 |
|
|
2022
Q3 | $20.6M | Sell |
859,240
-64,160
| -7% | -$1.54M | 2.58% | 15 |
|
|
2022
Q2 | $17.8M | Sell |
923,400
-257,100
| -22% | -$4.95M | 1.79% | 25 |
|
|
2022
Q1 | $20.5M | Buy |
1,180,500
+22,940
| +2% | +$399K | 1.37% | 31 |
|
|
2021
Q4 | $25.3M | Sell |
1,157,560
-57,110
| -5% | -$1.25M | 1.38% | 26 |
|
|
2021
Q3 | $23.2M | Sell |
1,214,670
-536,672
| -31% | -$10.3M | 1% | 29 |
|
|
2021
Q2 | $30.1M | Buy |
1,751,342
+379,862
| +28% | +$6.52M | 1.2% | 30 |
|
|
2021
Q1 | $30.7M | Buy |
1,371,480
+300,930
| +28% | +$6.73M | 1.09% | 32 |
|
|
2020
Q4 | $23.8M | Buy |
1,070,550
+1,038,350
| +3,225% | +$23.1M | 0.92% | 32 |
|
|
2020
Q3 | $475K | Buy |
+32,200
| New | +$475K | 0.02% | 38 |
|